Skip to main navigation
Akero
Akero
  • Overview
  • Press Releases
  • Presentations, Events & Webcasts
  • Stock Information
  • SEC Filings
  • Corporate Governance
    • Governance Overview
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Governance Overview

Governance Overview

Committee Charters
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Audit Committee Charter
Governance Documents
Corporate Governance Guidelines
Code of Business Conduct and Ethics
  • Print
  • RSS Feeds
  • Email Alerts
  • Contact IR
  • About
  • R & D
  • Efruxifermin
  • Investors
  • What is Nash?
  • Contact
© 2021 Akero Therapeutics, Inc. All rights reserved. Terms of Use.
Scroll to top